Relief Polyclinics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 M
- Revenue Growth -4.42%
- Profit Growth -78.69%
- Ebitda -47.00%
- Net Worth 16.26%
- Total Assets -22.10%
About Relief Polyclinics
Relief Polyclinics Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 September 2013 and has a history of 11 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.20 M.
Lakshmi Rangineni and Sunil Chiti serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100TG2013PTC089792
- Company No.
089792
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Relief Polyclinics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Chiti  | Director | 02-Sep-2013 | Current |
| Lakshmi Rangineni | Director | 02-Sep-2013 | Current |
Financial Performance of Relief Polyclinics.
Relief Polyclinics Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.42% decrease. The company also saw a substantial fall in profitability, with a 78.69% decrease in profit. The company's net worth Soared by an impressive increase of 16.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relief Polyclinics?
In 2019, Relief Polyclinics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Relief Pharma Private LimitedLakshmi Rangineni and Sunil Chiti are mutual person
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2024 | Hdfc Bank Limited | ₹1.20 M | Open |
How Many Employees Work at Relief Polyclinics?
Unlock and access historical data on people associated with Relief Polyclinics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relief Polyclinics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relief Polyclinics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.